Corporate
Top
Blood and Cell Technologies Company
Terumo Blood and Cell Technologies
Unlocking the potential of blood and cells for patients and their quality of life
Blood and cells in the human body are indispensable to sustaining life. They are also used every day as essential medicine, from blood transfusions to therapies that treat cancer and other serious diseases. The Blood and Cell Technologies Company plays a vital role in the collection, processing, development, and delivery of those treatments with solutions that help raise standards for quality and efficiency. The company supports customers such as hospitals, blood and plasma centers, researchers, and cell therapy developers with a strong focus on increasing patient access to high-quality, life-impacting care and new treatment options.
Main Products
Note: The regulatory approval status and availability of these products differ by country or region.
Plasma Innovations
We offer a plasma collection ecosystem that combines patented technology with services, program support, and IT solutions. The system helps plasma collection centers optimize productivity, collections, and the donor experience and meet the needs of patients who rely on plasma-derived therapies to treat serious illnesses.
Plasma donation system
Global Blood Solutions
Our automated solutions bring higher quality and efficiency to blood collection and component preparation processes.
Automation enables blood center professionals to select the best possible combination of components from each donor, yielding the right products to meet individual patient needs.
Whole blood collection
Blood bag sets with leukocyte filters
Blood component collection
Automated blood collection system
Whole blood separation and component production
Automated blood processing system
Pathogen reduction technology
Pathogen reduction system
Therapeutic Solutions
Apheresis systems can separate blood into components, remove disease-associated elements, and return the rest to the patient. It can also remove targeted cells and replace them with healthy donor cells. Apheresis-based therapies have applications for various health conditions such as leukemia and sickle cell disease. Our system can also be used for subtractive immunotherapies using secondary, highly selective filtering devices.
Centrifugal apheresis system
Cell Therapy Technologies
Pharmaceutical and biotech companies depend on donor cells to enable their research and drug manufacturing in the rapidly evolving market of cell and gene therapies. We help transform traditionally small-scale, manual cell development into automated processes that meet the needs of commercial manufacturing to advance therapies for more patients.
Cell expansion system
Cell therapy fill and finish system
Related Links
